Litcius/Paper detail

Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum

Katharina Habler, Mathias Brügel, Daniel Teupser, Uwe Liebchen, Christina Scharf, Ulf Schönermarck, Michael Vogeser, Michael Paal

2021Journal of Pharmaceutical and Biomedical Analysis94 citationsDOIOpen Access PDF

Topics & Concepts

RitonavirLopinavirChemistryFavipiravirChromatographyTherapeutic drug monitoringMetaboliteHydroxychloroquineAnalytePharmacologyDrugVirologyCoronavirus disease 2019 (COVID-19)Viral loadVirusMedicineDiseaseInfectious disease (medical specialty)Antiretroviral therapyBiochemistryPathologyPesticide Residue Analysis and SafetyAnalytical Methods in PharmaceuticalsAntibiotics Pharmacokinetics and Efficacy
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum | Litcius